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ABSTRACT 
 
Objective: The objective of this thesis was to assess outcomes of glenohumeral 
corticosteroid injections for adhesive capsulitis. 
Design: The thesis was composed of two parts. First, a systematic literature 
review was conducted on glenohumeral corticosteroid injections on shoulder 
outcomes for adhesive capsulitis. Second, an original prospective study was 
conducted to measure the effect of ultrasound-guided injections on pain and 
function for adhesive capsulitis patients. 
Setting: All injections for the prospective injection study were conducted at 
Brigham and Women’s Hospital in Boston, MA. 
Patients: Inclusion criteria were patients receiving an ultrasound guided injection 
for adhesive capsulitis. 67 patients were included, 59 patients were available at 
first follow up, and 40 patients were available at final follow up. 
Methods: The literature review was conducted using the online databases 
PubMed (1966-present), Embase (1947-present), Web of Science (1900–
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present), and the Cochrane Central Register of Controlled Trials. Study criteria 
were limited to clinical trials that evaluated the application of corticosteroid 
injections, both alone and in combination with other treatment modalities, 
specifically for the condition of adhesive capsulitis in the shoulder. Studies 
involving non-corticosteroid injections or injections for conditions not specific to 
adhesive capsulitis were excluded. Results were limited to papers in the English 
language. A data table summarizing pain, function, and range of motion 
outcomes of each treatment was produced. A percent change from baseline was 
calculated to facilitate comparisons. For the injection study, the first follow-up 
took place after an average of 2.0 months and patients’ improvement in pain and 
range of motion were assessed. During a final follow-up after an average of 10.4 
months, patients’ pain and shoulder function scores were assessed over 
telephone. 
Main Outcome Measurements: The main outcome measurements for the 
injection study were visual analog scale (VAS), subjective shoulder value (SSV), 
and the range of motion (ROM) parameters forward flexion, isolated abduction, 
and external rotation. 
Results: The literature review included 25 studies. They were then organized 
into seven groups according to comparison group. All studies showed 
improvements in pain and range of motion at the end of the study. Corticosteroid 
injections offer rapid pain and motion relief in the first few weeks of treatment 
although most studies showed no differences in treatment groups at the end of 
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their study periods. The prospective injection study showed that after first follow 
up, patients had a mean of 123.1˚ in forward flexion, 80.6˚ in isolated abduction, 
45.3˚ in external rotation, 3.2 in average pain, 5.0 in worst pain, and 79.3 in 
subjective shoulder value (SSV). At final follow up, patients had a mean score of 
2.2 in average pain, 3.0 in worst pain, and 76.7 in SSV. Patients had an average 
of 78.0% overall improvement in shoulder pain, with 57.5% of patients gaining > 
75% pain relief in less than 3 months. Patients had an average of 81.1% overall 
improvement in shoulder function, with 47.5% of patients gaining > 75% range of 
motion improvement in less than 3 months. 
Conclusions: The literature review showed that corticosteroid injections rapidly 
relieve pain and improve range of motion for adhesive capsulitis patients 
although conclusions cannot be made for the long term. There is a need for more 
conclusive studies to determine the effectiveness of ultrasound-guided injections 
for adhesive capsulitis. The injection study showed ultrasound guided injections 
offer rapid shoulder pain and range of motion relief for most patients within 6 
months. 
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INTRODUCTION 
Adhesive capsulitis is a long lasting, painful shoulder condition commonly 
known as “frozen shoulder”. Patients also experience severe loss of range of 
motion (ROM) of the glenohumeral joint in the shoulder. It is believed the 
condition results from progressive fibrosis and eventual contracture of the 
capsule of the glenohumeral joint. The contracture of the capsule is responsible 
for limiting motion and causing pain (Hashiuchi, Sakurai, Sakamoto, Takakura, & 
Tanaka, 2010; A. S. Neviaser & Neviaser, 2011). 
 
BACKGROUND  
Epidemiology 
Adhesive capsulitis is believed to be found in about 2% of the general 
population (Tasto & Elias, 2007). Most patients are between the ages of 40-60 
and many are women (Boyle-Walker, Gabard, Bietsch, Masek-VanArsdale, & 
Robinson, 1997; A. S. Neviaser & Hannafin, 2010; Tasto & Elias, 2007). 
Adhesive capsulitis is also found frequently amongst diabetic patients (Balci, 
Balci, & Tüzüner, 1999; Tasto & Elias, 2007). Up to 29% of type II diabetics may 
present with this condition (Balci et al., 1999). Type I diabetics have a 40% 
chance of developing adhesive capsulitis in their lifetimes (Tasto & Elias, 2007). 
Other conditions found to be associated with adhesive capsulitis are 
hyperthyroidism, hypothyroidism, Parkinson’s disease, cardiac disease, and 
autoimmune disorders (Bowman, Jeffcoate, Pattrick, & Doherty, 1988; Tuten et 
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al., 2000; Wohlgethan, 1987; Wolf & Green, 2002) . One study found 
development of adhesive capsulitis to be associated with impairment of 
consciousness, hemiparesis, duration of post-operative intravenous infusion, 
age, and depressive personality (Bruckner & Nye, 1981).  
 
Diagnosis 
Adhesive capsulitis presents with a spontaneous onset of shoulder pain 
followed by loss of both active and passive shoulder motion (Griesser, Harris, 
Campbell, & Jones, 2011). Adhesive capsulitis is a clinical diagnosis. A diagnosis 
is usually made based on patient history and physical examination (A. S. 
Neviaser & Hannafin, 2010). The key clinical feature in diagnosis is the restriction 
of passive shoulder ROM, particularly in forward flexion, abduction, external 
rotation, and internal rotation (A. S. Neviaser & Hannafin, 2010; Weinstein & 
Buckwalter, 1994). The restriction is described to be a true mechanical restriction 
rather than one limited by pain (Basow, 2013; A. S. Neviaser & Neviaser, 2011). 
Another essential factor of an adhesive capsulitis diagnosis is the significant loss 
of humeral rotation with the arm in neutral position and with the arm in 90 
degrees of abduction and elbow flexed to 90 degrees (Baratz, Watson, & 
Imbriglia, 1999). Radiologic findings are usually normal. However, they can be 
useful for ruling out other shoulder conditions such as osteoarthritis or dislocation 
(Brue et al., 2007; Manske & Prohaska, 2008; A. S. Neviaser & Neviaser, 2011; 
Tasto & Elias, 2007). 
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Natural History and Pathophysiology 
The specific pathophysiology of adhesive capsulitis is still unknown. In 1945, 
Neviaser described the pathology as the thickening and contraction of the 
shoulder capsule which then becomes adherent to the humeral head, causing 
stiffness and pain in the shoulder (J. Neviaser, 1945). The glenohumeral joint 
capsule is tight and thickened with “adhesions obliterating the axillary fold” 
(Figure 1) (A. S. Neviaser & Neviaser, 2011).  
  
Figure 1: Axillary fold of the glenohumeral joint obliterated with adhesions 
Adhesive capsulitis is characterized by a fibrotic capsule that adheres to the neck 
of the humeral head. The glenohumeral joint is tightened and thickened, causing 
pain and stiffness. (Adapted from A. S. Neviaser & Neviaser, 2011). 
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There is also loss of synovial fluid volume (A. S. Neviaser & Neviaser, 2011; 
Tasto & Elias, 2007). Histological studies have supported evidence of synovial 
inflammation with subsequent reactive capsular fibrosis (Brue et al., 2007; Hand, 
Athanasou, Matthews, & Carr, 2007). One study obtained biopsy material from 
the rotator interval area in the shoulder capsule. Using CD3, CD20, CD68, and 
mast cell tryptase antibodies, they found inflammatory infiltrate predominantly in 
the form of mast cells, macrophages, and T cells, indicating a chronic 
inflammatory cell infiltrate (Hand et al., 2007). Another study linked elevated 
levels of the cytokines TGF-β and platelet-derived growth factor to the 
inflammation and fibrosis found in adhesive capsulitis (Rodeo, Hannafin, Tom, 
Warren, & Wickiewicz, 1997). However, altering the natural history of adhesive 
capsulitis and shortening recovery time is challenging because its specific 
causes remain unknown. 
The natural history of adhesive capsulitis is described in three consecutive 
stages (Griesser et al., 2011; Tasto & Elias, 2007). The first stage, known as the 
“freezing” stage, is marked by an onset of progressive pain and loss of ROM that 
lasts for up to nine months. Hypovascular synovitis is seen in this stage. The 
second stage or the “frozen” stage is marked by improvements in pain but 
stiffness persists and impacts patients’ ability to perform activities of daily living.  
Hypovascularity and synovitis decreases in this stage. The third and final 
“thawing” stage is a period of recovery marked by gradual improvement in range 
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of motion that can take up to five to twenty-six months. Synovitis is not seen in 
this final stage. 
Adhesive capsulitis is a self-limiting condition. Restoration of range of motion 
and resolution of symptoms occur within two years (Grey, 1978). However, some 
studies have shown residual symptoms of adhesive capsulitis. Binder et al. found 
that some residual shoulder restriction in total flexion, abduction, and external 
rotation continued to persist in 40% of patients after three years as compared to 
a matched control group (Binder, Bulgen, Hazleman, & Roberts, 1984). Shaffer 
et al. reported that 60% of patients who underwent either non-operative 
treatment including injections or operative treatment had restriction in at least 
one plane of motion after an average follow-up period of seven years. Reeves 
found that only 16 of 41 patients, treated with an arm sling and analgesics to 
relieve pain, had full recovery after a follow-up of five years. Recovery was 
assessed in comparison to the contralateral shoulder’s range of motion (Reeves, 
1975).  
 
Treatments 
There are several treatment options available for adhesive capsulitis. Usually, 
a combination of treatments is administered which may include non-steroidal 
anti-inflammatory drugs (NSAIDs) or other drug treatments, physical therapy, 
manipulation under anesthesia (MUA), dilation or distension, arthroscopic or 
open release, or injections of sodium hyaluronate or corticosteroids (Blockey, 
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Wright, & Kellgren, 1954; Buchbinder et al., 2004; De Carli et al., 2012; Tveitå, 
Tariq, Sesseng, Juel, & Bautz-Holter, 2008).  
Physical therapy may involve active exercises such as pendulum or Codman 
exercises within the pain threshold (Arslan & Çeliker, 2001; Diercks & Stevens, 
2004).  Physical therapy may also involve a more aggressive course of passive 
stretching such as Maitland mobilizations and manipulation of the shoulder joint 
past the pain threshold (Diercks & Stevens, 2004; Ryans, Montgomery, Galway, 
Kernohan, & McKane, 2005). One prospective study found that after 24 months, 
frozen shoulder patients who received the more intensive physical therapy 
treatment of passive stretching and manual mobilization were less likely to reach 
normal or near-normal shoulder function (defined as reaching a Constant score ≥ 
80) compared to the group that received therapy and performed exercises within 
pain limits (Diercks & Stevens, 2004). 
In manipulation under anesthesia, patients are placed under anesthesia and 
with the scapula stabilized, the affected arm is forcibly moved in certain planes of 
motion including flexion, external rotation, and internal rotation (De Carli et al., 
2012; Jacobs, Smith, Khan, Smith, & Joshi, 2009; Kivimäki & Pohjolainen, 2001). 
Dilation or distension involves injecting a large amount of a solution that can 
consist of either air, steroid, anesthetic, or saline into the glenohumeral joint to 
distend the capsule and to break up capsular adhesions (Quraishi, Johnston, 
Bayer, Crowe, & Chakrabarti, 2007). Arthroscopic release and open surgical 
release are less common procedures used for debridement and to release 
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contracture of the capsule (A. S. Neviaser & Hannafin, 2010). Hyaluronate is a 
glycosaminoglycan with a lubricating effect that is injected to prevent the 
formation of adhesions (Harris, Griesser, Copelan, & Jones, 2011).  
Intra-articular corticosteroid injections are a treatment option that targets the 
inflammatory process of adhesive capsulitis at the site of its pathology, the 
glenohumeral joint. (Bal et al., 2008; A. S. Neviaser & Neviaser, 2011). To 
improve the accuracy of injections, and perhaps enhance symptomatic relief, 
image guidance in the form of fluoroscopy or ultrasound is used. However, there 
is still a need for high quality studies to demonstrate efficacy of corticosteroid 
injections in the treatment of adhesive capsulitis and even more so for studies 
investigating the accuracy and effectiveness of image guided injections. 
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Specific Aims 
Thus, we investigated the effectiveness of ultrasound-guided corticosteroid 
injections for adhesive capsulitis in two ways. First, we conducted a systematic 
literature review that assessed outcomes of corticosteroid injections for adhesive 
capsulitis. We also assessed the outcomes of image-guided corticosteroid 
injections. Second, we designed and conducted an original study that measured 
improvements in shoulder pain and function amongst patients who received an 
ultrasound-guided injection. More specifically our study aimed to: 
1) Report a systematic literature review on corticosteroid injections and 
image-guided corticosteroid injections in the treatment of adhesive 
capsulitis by following the PRISMA guidelines for reporting systematic 
reviews 
2) Prospectively follow patients who received an ultrasound guided injection 
for the treatment of adhesive capsulitis for 1 to 18 months 
3) Evaluate the clinical efficacy of ultrasound-guided corticosteroid injections 
by determining patients’ improvements in shoulder function and pain 
We hypothesized that corticosteroid injections will improve range of motion. 
Since the natural history of adhesive capsulitis is improvement in pain after 6-9 
months, we hypothesized that patients receiving injections will also have pain 
relief. We also hypothesized that image guided injections will provide greater 
improvements in recovery than non-image guided injections.  
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METHODS 
Systematic Review Methods 
The systematic literature review was formatted and based upon guidelines 
suggested by “The PRISMA Statement for Reporting Systematic Reviews and 
Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation 
and Elaboration”, which seeks to provide a method of producing more 
standardized and complete systematic reviews (Liberati et al., 2009).  
Study criteria were limited to clinical trials including randomized trials, 
prospective studies, and retrospective studies that evaluated the application of 
corticosteroid injections, both alone and in combination with other treatment 
modalities, specifically for shoulder adhesive capsulitis. Studies excluded from 
this review were those receiving injections for subacromial bursitis, shoulder 
impingement, or for generalized shoulder stiffness or pain. Studies involving 
injections of sodium hyaluronate or other non-corticosteroids were excluded. 
Other limits included papers written in the English language and those involving 
human subjects. 
The literature search was conducted by searching the online databases 
PubMed (1966-present), Embase (1947-present), Web of Science (1900–
present), and the Cochrane Central Register of Controlled Trials. The search was 
conducted in September 2012. We used the following search terms for the 
search of the databases: shoulder, adhesive capsulitis, frozen shoulder, 
ultrasound, corticosteroid, injections, and intra-articular. The data collecting 
process began with the creation of a data extraction table organizing and 
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summarizing the results of each included study. Our search strategy is depicted 
in Figure 2. The initial search returned 859 studies. 630 studies were excluded 
after filtering for clinical trials with human subjects in the English language. After 
screening for titles and abstracts and adjusting for duplicates, 35 unique articles 
were retrieved. Upon additional screening for inclusion criteria, a total of 25 
studies were identified for inclusion. The final yield included 7 prospective 
studies, 16 randomized trials, and 2 retrospective studies. The bibliography of 
review articles and articles selected for final inclusion was also manually 
searched for any relevant articles. Data items extracted from each study 
included: study design, study population, diagnosis, mean patient age, duration 
of study, intervention, single or multiple injections, location of injections, control 
population (if any), follow up period, and outcome measurements. Risk of bias in 
individual studies was assessed, when possible, by determining concealment of 
randomization, blinding of patients, health care providers, data collectors, and 
outcome assessors.  
There was inconsistency in the outcome measures for pain and ROM used 
across studies. Also, outcome measurements for pain, range of motion, and 
function varied widely which included passive and active range of motion 
measures, visual analog scale (VAS), shoulder disability questionnaire (SDQ), 
shoulder pain and disability index (SPADI), SF-36 (Short Form 36 Health 
Survey), and Constant-Murley score. In order to facilitate comparisons across 
studies, we calculated a percent change of outcome measures when it was  
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Figure 2: A flow diagram of study selection.  
The search process was conducted in September 2012. Studies were then 
screened for inclusion. The final yield included 25 studies. 
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feasible to do so. We did not statistically combine data or conduct a meta-
analysis because outcome measure results amongst studies were too 
heterogeneous. In addition to outcome measure, studies varied widely in 
interventions, study design, and comparison group. Risk of bias in individual 
studies was assessed. We determined if concealment of randomization, blinding 
of patients, health care providers, data collectors, and outcome assessors had 
been reported for included randomized trials. However, not all of the included 
studies were randomized trials and thus certain risk of bias assessments did not 
apply for all studies. 
 
Injection Study Methods 
Patients receiving ultrasound guided corticosteroid injections from June 1, 
2011 to December 31, 2012 at Brigham and Women’s Hospital were identified 
using billing records. Electronic medical records were searched and analyzed to 
determine which patients had received an injection for adhesive capsulitis. A 
diagnosis of adhesive capsulitis was determined by one of three physicians. 
Patients who received injections for osteoarthritis, biceps tenosynovitis, 
subacromial/subdeltoid burstitis, acromioclavicular joint localization, non-shoulder 
injections, and in ections for other conditions were excluded. The study was 
limited to English speaking patients only. 
At the initial evaluation, baseline measures including duration of symptoms at 
time of visit, average pain, worst pain, subjective shoulder value, forward flexion, 
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isolated abduction, and external rotation were noted. Range of motion was 
measured at this point was also assessed. Patients reported average and worst 
pain using the visual analog scale (VAS). 
All injections were performed by a single physician (NJ). Patients were 
injected using a posterior, lateral to medial, approach while  sitting with the elbow 
flexed at 90 degrees and the arm supported in neutral position or in a lateral 
decubitus position. The area was prepped and draped in a sterile fashion with 
chlorhexidine and isopropyl alcohol. The spine of the scapula was palpated. 
Using a sterile technique with a sterile transducer cover, the glenohumeral joint 
was visualized under ultrasound with either a 5.5 megahertz convex transducer 
or a 13-8 megahertz linear transducer lateral and inferior to the spine of the 
scapula. The head of the humerus and the glenoid were visualized under 
ultrasound.  
Using sterile technique, a 20 or 21 gauge spinal needle was advanced slowly 
in plane, lateral to infero-medial, until its tip was visualized under ultrasound to be 
in the glenohumeral joint space. 4 milliliters of 2% lidocaine or 1% lidocaine and 
40 milligrams of triamcinolone acetonide (Kenalog, Bristol-Myers Squibb 
Company, Princeton, NJ, USA) were in ected into the  oint and the  oint capsule 
was noted to distend with the fluid. After the needle was withdrawn, the site was 
covered with a sterile bandage. The patient was discharged after short 
observation if the procedure was well tolerated. All patients were prescribed a 
physical therapy or home exercise program. 
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The first follow-up occurred after a mean of 2.0 months (n = 59). 47 patients 
returned to the clinic for their first follow-up and 12 patients conducted their 
follow-up through the telephone injection questionnaire as described below. For 
patients returning to the clinic for follow-up, range of motion was measured again 
at this point. All patients reported average and worst pain using the visual analog 
scale. If necessary, physical therapy was assigned at this stage.  
A telephone call was made to patients for final follow-up (n = 40). Time period 
of follow up ranged from 4 to 18 months with a mean of 10.4 months. Before the 
call was placed, a participation sheet was mailed to each of the patients that 
requested their participation in the study. Phone calls were made after patients 
had replied with the participation sheet or after 2 weeks had passed without a 
response from the patient. During the call, patients were asked a series of seven 
questions pertaining to the pain and function of their affected shoulder(s). The 
complete telephone questionnaire can be found in Appendix A. In the final follow-
up, subjective shoulder value, average pain, worst pain, overall pain 
improvement, overall range of motion improvement, time period to get > 75% of 
pain relief, and time period to get > 75% range of motion relief. 
IRB approval was obtained for this study from our institution. 
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RESULTS 
Systematic Review Results 
Of the 25 studies that were included for review, there were a total of 1429 
subjects. 7 studies were prospective studies, 16 studies were randomized trials, 
and 2 were retrospective studies. The total duration of follow-up in these studies 
ranged from 4 weeks to 3 years. All interventions involved at least one intra-
articular corticosteroid injection. Several studies used a combined treatment 
approach in which one or more steroid injections were provided in conjunction 
with another treatment (such as corticosteroid injection and supervised physical 
therapy).  
We categorized the included studies by comparison group to the steroid 
injection intervention, if any (Table 1). 2 studies (n = 124) analyzed the steroid 
injection group alone or compared to a placebo injection. 6 studies (n = 460) 
compared injections with physical therapy, 3 studies (n = 113) compared 
injections with manipulation under anesthesia (MUA), 2 studies (n = 96) 
compared injections with dilation/distension, 6 studies (n = 435) compared either 
steroid injection dosages, anatomical location of the injection, or types of steroid, 
4 studies (n = 136) evaluated treatment protocols that combined an injection with 
distension, dilation, or MUA, and 2 studies (n = 65) specifically examined image-
guided injections. 
Risk of bias within each individual randomized trial study was assessed 
(Table 2). Four prospective and two retrospective studies were not analyzed 
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because risk of bias assessment was not applicable. Seven randomized trials 
reported concealment of randomization, four reported blinding patients, three 
reported blinding health care providers, one reported blinding data collectors, and 
eight reported blinding outcome assessors. 
 
Table 1: Studies by comparison group 
The included studies all involved at least one injection of a corticosteroid to the 
glenohumeral joint in the treatment of adhesive capsulitis. The included studies 
were then organized by comparator to the injection. 
 
TABLE 1: Studies by comparison group 
Comparators Number 
of studies 
Number of 
subjects 
Steroid Injection Alone or 
Steroid Injection vs. Placebo 
Injection 
2 124 
Steroid Injection vs. 
Supervised Physical Therapy 
6 484 
Steroid Injection vs. 
Manipulation Under 
Anesthesia 
4 155 
Steroid Injection vs. 
Dilation/Distension 
2 96 
Comparison of steroid 
injection dosages, location of 
injection, or types of steroid. 
6 435 
Steroid injections in 
combination with distension, 
dilation, or MUA  
4 136 
Image-guided injections 2 65 
Total 26 1527 
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Table 2: Risk of bias within studies 
The 25 studies included in the review were individually evaluated for risk of bias. 
Study type, concealment of randomization, blinding of patients, health care 
providers, data collector, and outcome assessors were considered when 
possible.  
  
  
TABLE 2: Risk of bias within studies 
Trials Concealment 
of 
Randomization 
Patients 
Blinded 
Health Care 
Providers 
Blinded 
Data 
Collectors 
Blinded 
Outcomes 
Assessors 
Blinded 
Bal (2008) Yes Yes No NR Yes 
Arslan (2001) No No No NR NR 
Carette (2003) Yes Yes Yes NR Yes 
Ryans (2005) Yes Yes Yes NR NR 
Bulgen (1984) No No No NR Yes 
De Carli 
(2011) 
NR No No NR Yes 
Jacobs (2009) Yes No No NR NR 
Kivimaki 
(2001) 
No No No NR NR 
Gam (1998) Yes No No NR Yes 
Tveita (2008) Yes No No NR No 
De Jong 
(1998) 
Yes Yes Yes NR NR 
Lorbach 
(2010) 
No No No NR NR 
Oh (2011) No NR No Yes NR 
Rizk (1991) NR NR NR NR Yes 
White (1996) NR No No No NR 
Lee (2009) NR No No NR Yes 
*NR = not reported 
Prospective and retrospective studies were not applicable for risk of bias analysis (Ahmad et 
al., 2009; Laroche, Ighilahriz, Moulinier, Constantin, & Mazieres, 1998; Levine et al., 2007; 
Lorbach, Kieb, et al., 2010; Mitra, Harris, Umphrey, Smuck, & Fredericson, 2009; Quraishi et 
al., 2007; Sakeni & Al-Nimer, 2007; Sharma, Bajekal, & Bhan, 1993; Siraj et al., 2012) 
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 Appendix B provides a summary of the data. All studies found improvements 
in nearly all ranges of motion and pain scores. Two studies examined steroid 
injection alone or compared to a placebo injection. In range of motion scores, 
Ahmad et al. found their subjects had a mean 58% improvement in abduction 
and a 100% increase in internal rotation (Ahmad et al., 2009). A randomized trial 
by Bal et al. compared a group receiving a steroid injection to a group receiving a 
placebo injection found a 67.4% increase in abduction and a 63.6% increase in 
internal rotation after 12 weeks. However, the placebo injection group found a 
77.7% increase in abduction and an 89.4% increase in internal rotation after 12 
weeks. In improvements in pain, the Ahmad et al. study showed a 60% VAS 
score decrease while in the Bal et al. study, the steroid group showed an 83.1% 
decrease in SPADI pain score while the control group showed an 81.1% 
decrease in a SPADI pain score (Bal et al., 2008). 
The next group of studies compared steroid injection to physical therapy. One 
study compared a 40 mg methylprednisolone acetate injection to a regimen of 
physical therapy for 12 weeks. In the injection group, they saw increases of 48% 
in passive abduction, 23% in passive internal rotation, 97% in passive external 
rotation, and 30.8% in passive flexion compared to increases of 54.1% in passive 
abduction, 24.7% in passive internal rotation, 75.1% in passive external rotation, 
and 43.8% in passive flexion in the physical therapy group. The injection group 
also showed a 72.6% decrease in VAS score while the physical therapy group 
showed a 68.6% decrease (Arslan & Çeliker, 2001). In another study, the group 
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receiving a corticosteroid injection of triamcinolone hexacetonide had a mean 
increase of ROM of 12.9 degrees in passive abduction, 18.3 degrees in external 
rotation, and 16.0 degrees in passive flexion while the group receiving a saline 
injection followed by supervised physical therapy had a mean increase of 14.2 
degrees in passive abduction, 9.7 degrees in external rotation, and 9.6 degrees 
in passive flexion. This study also showed that the group receiving both an 
injection and physical therapy had a mean increase of 21.0 degrees in passive 
abduction, 26.5 degrees in external rotation, and 29.7 degrees in passive flexion. 
The corticosteroid injection alone group had a 39.1 point decrease in SPADI pain 
scores and the saline injection and physical therapy group had a 21.8 point 
decrease, and the injection with physical therapy group had a 46.5 point 
decrease (Carette et al., 2003). A third study found a 28.4 point decrease in VAS 
for the group receiving an injection of triamcinolone 20 mg with no physical 
therapy compared to a 26.1 point decrease in the group receiving a placebo 
injection and physical therapy (Ryans et al., 2005). A retrospective study by 
Levine et al. found similar changes in external and internal rotation between a 
physical therapy only group and a physical therapy and injection group (Levine et 
al., 2007). A prospective study by Siraj et al. saw a 75.2% reduction in SPADI-
total score after 4 weeks in a group treated with methylprednisolone injection 
followed by physical therapy (Siraj et al., 2012). 
 Four studies considered shoulder manipulation under anesthesia (MUA) 
versus injection. One study compared a group of patients who had received an 
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MUA treatment with those that had received a methylprednsiolone acetate 
injection protocol and evaluated shoulder function across four different scales 
(Constant-Murley score, UCLA shoulder scale, American Shoulder and Elbow 
Surgeons score (ASES), and the Simple Shoulder Test (SST)). Patients who 
received the manipulation had greater increases in the Constant-Murley score 
and the Simple Shoulder Test score (a 143.2% and a 484% increase, 
respectively) than the patients who received an injection (45% and 186% 
increases). However, the injection group had larger increases in the other two 
shoulder scores, UCLA scale (150% vs. 107.9%) and ASES score (122% vs. 
81.7%) (De Carli et al., 2012). Another study compared a group of patients 
receiving manipulation with steroid injection and another receiving manipulation 
without steroid injection. While the study found a 425% increase in inner rotation 
for the manipulation only group, those that received both the manipulation and 
the injection had a greater improvement in flexion (54% vs. 46%), abduction 
(77% vs. 76%), and outer rotation (81% vs. 68%) (Kivimäki & Pohjolainen, 2001). 
One study found similar decreases in VAS for the MUA group and a group 
treated with injection and distension (2.75 vs. 2.77) (Jacobs et al., 2009). Bulgen 
et al. found similar improvements in VAS, abduction, flexion, and external 
rotation at the end of six months amongst treatment groups of injection, 
mobilizations, ice therapy, and no treatment (Bulgen, Binder, Hazleman, Dutton, 
& Roberts, 1984) 
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Two studies compared an injection with dilation or distension of steroid. 
Tveita et al. found that compared to the dilation group, there were greater 
increases in the injection group in measures of passive abduction (48% vs. 42%), 
flexion (35% vs. 33%), and external rotation (105% vs. 69%) but identical 
improvements in internal rotation (31%). However, the dilation group reported a 
greater decrease in pain score (66%) compared to the injection group (59%) 
(Tveitå et al., 2008). Gam et al. showed that at 7 and 12 weeks, dilation with 
steroid and anesthetic had favorable improvements in extension and external 
rotation but not in abduction compared to the improvements from steroid injection 
alone (Gam, Schydlowksy, Rossel, Remvig, & Jensen, 1998). However, the 
results of these findings were not quantified.  
Other studies compared steroid dosages, location of injection, or types of 
steroid. de Jong et al. found a mean VAS improvement of 49.3 for a higher 
dosage of triamcinolone acetonide (40 mg) compared to a 31.2 VAS 
improvement for a lower dosage of triamcinolone acetonide (10 mg) (De Jong, 
Dahmen, & Hogeweg, 1998). Lorbach et al. compared a treatment protocol of 
corticosteroid injection (5 mL of bupivacaine (0.5mg), 5 mL of mepivacaine 
(0.5mg), and 40 mg of triamcinolone) and an oral corticosteroid (prednisolone 40 
mg) taper. In the injection group, they found increases of 119% in abduction, 
55% in flexion, 260% in external rotation, and 26% in internal rotation. In the oral 
steroid group, they found increases of 94% in abduction, 93% in flexion, 900% in 
external rotation, and 44% in internal rotation (Lorbach, Anagnostakos, et al., 
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2010). Three of the studies compared the location of injection in the shoulder. Oh 
et al. found a glenohumeral injection had a 4.5 point decrease in VAS compared 
to a 3.8 decrease in a subacromial injection (Oh et al., 2011). Another study 
compared intra-articular injections to intra-bursal injections. Intra-articular 
injections of methylprednisolone had an 8% increase in abduction, a 20% 
increase in external rotation, a 31% increase in internal rotation, and an 11% 
increase in flexion. Intra-bursal injections also had an 8% increase in abduction, 
but a 36% increase in external rotation, a 22% increase in internal rotation, and a 
7% increase in flexion. 
The next group of studies investigated a combined treatment approach, using 
a mix of distension, injection, and MUA for instance. A study by Laroche et al. 
prospectively followed a group of subjects treated with distension during 
arthography followed by intra-articular corticosteroid injection, followed by 
physical therapy, and then use of an abduction splint (Laroche et al., 1998). Mitra 
et al. applied a suprascapular nerve block, 2 injections of triamcinolone 80 mg 
with lidocaine followed by brisement normal saline volume dilation, and then 
manipulation of the shoulder (Mitra et al., 2009). Sharma et al. compared a MUA 
treatment group to a group receiving a methylprednisolone injection followed by a 
saline joint distension (Sharma et al., 1993). In terms of changes in abduction, 
Laroche et al. showed a 58% increase, Mitra et al. showed a 51.7 degree 
improvement, and the Sharma et al. showed a 130% increase for the MUA group 
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and a 203% increase for the injection and distension group (Laroche et al., 1998; 
Mitra et al., 2009; Sharma et al., 1993). 
 The final group of studies involved ultrasound or fluoroscopically guided 
steroid injections. Lee et al. compared ultrasound guided injections of 
triamcinolone with blind injections. After 6 weeks, the ultrasound guided injection 
group had improvements of 42% in abduction, 42% in flexion, 62% in external 
rotation, and 131% in internal rotation. The blind group had similar improvements 
of 50% in abduction, 0% in flexion, 67% in external rotation, and 141% in internal 
rotation (Lee, Lim, Kim, & Lee, 2009). Lorbach et al. prospectively followed a 
cohort of subjects who had received 3 fluoroscopically-guided injections of 40 mg 
of triamcinolone followed by physical therapy and had improvements of 181% in 
abduction, 52% in flexion, 257% in external rotation, and 26% in internal rotation 
(Lorbach, Kieb, et al., 2010). 
  
Injection Study Results 
383 patients received ultrasound guided injections from June 1, 2011 to 
December 31, 2012 as identified using billing records. 67 patients were identified 
as receiving injections for adhesive capsulitis (39 left shoulders, 36 right 
shoulders). 45 (67.2%) patients were female and 22 (32.8%) were male. The 
average duration of pain at the time of visit was 6 months (0.5 to 25 months). 47 
patients returned to the clinic for the first follow-up. 4 patients received a second 
injection because they did not find pain or shoulder function relief from the first 
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one. 40 patients were available for the final follow up over telephone – 8 patients 
could not be contacted, 7 patients refused follow up, and 4 non-English speaking 
patients were excluded from the final follow-up over telephone.  
Table 3 shows a summary of outcome measures before the injection and at 
each follow-up period. Patients returned to the clinic for first follow-up after a 
mean of 2.0 months. Final follow-up was conducted over telephone at a mean of 
10.4 months. Both mean average and worst pain decreased at each follow-up 
period but the change was only significant after the first follow-up (Figure 3). 
Mean average pain decreased from 5.48 ± 0.54 to 3.24 ± 0.85 at the first follow 
up to 2.18 ± 0.68 at the final follow up.  Mean worst pain decreased from 8.35 ± 
0.37 to 4.96 ± 1.36 at the first follow up to 2.99 ± 0.83 at the final follow up. 
Subjective shoulder value (SSV) increased at every follow up period, but the 
increase was statistically significant only after the first follow-up period (Figure 4). 
SSV improved from 49.24 ± 8.87 to 70.00 ± 8.42 after first follow-up and to 76.70 
± 7.26 at final follow-up. 
Range of motion improved after the first follow-up period (Figure 5). Mean 
forward flexion significantly improved from 99.93 ± 6.52 to 124.26 ± 7.22, a 
24.3% increase.  Isolated abduction significantly improved from 58.91 ± 5.41 to 
80.68 ± 5.36, a 37.0% increase. External rotation improved from 39.29 ± 5.16 to 
45.47 ± 7.24, a 15.7% increase, but the increase was not significant. 
The final follow-up period showed that the mean overall improvement in 
shoulder pain after the injection was 78.0%. Mean overall improvement in 
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shoulder function after the injection was 81.1%. The final follow-up also showed 
that 57.5% of patients found greater than 75% pain relief in less than 3 months, 
75.0% of patients in less than 6 months, but 15.0% had not yet found greater 
than 75% pain relief at the time of follow-up. 47.5% of patients found greater than 
75% range of motion in less than 3 months, 72.5% of patients in less than 6 
months, but 10.0% had not yet found greater than 75% range of motion 
improvement at the time of the final telephone follow-up. Figure 6 shows the time 
periods and percentage of patients who achieved > 75% pain relief or > 75% 
range of motion improvement, if at all. 
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Table 3: Shoulder outcomes measures over study period 
Shoulder function, pain, and range of motion values were measured before 
injection, after first follow-up, and after final follow-up over telephone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Visual analog pain scores at baseline, first follow-up, and final follow-
up. 
Average pain and worst pain decreased at every follow-up period. 
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TABLE 3: Shoulder outcome measures 
Outcome Measure Before 
injection 
(n = 67) 
First follow-up 
(mean = 2.0 
months)  
(n = 59) 
Final phone 
follow-up (mean 
= 10.4 months) 
(n = 40) 
Subjective Shoulder 
Value (SSV) 
49.24 70.00 76.70 
 
Average pain 5.48 3.22 2.18 
Worst Pain 8.35 4.84 2.99 
Forward flexion 99.93 123.14 -- 
Isolated abduction 58.91 80.63 -- 
External rotation 39.29 45.29 -- 
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Figure 4: Subjective shoulder value (SSV) over the study period.  
SSV increased after the first follow-up and at final follow-up. However, the 
increase at final follow-up was not statistically significant. 
 
 
 
Figure 5: Range of motion (ROM) measures before injection and at first follow-
up.  
Forward flexion increased by 24.3 percent, isolated abduction increased by 37.0 
percent, and external rotation increased by 15.7 percent at first-follow-up. 
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Figure 6: The time period in which subjects achieved > 75% pain relief or > 75% 
range of motion improvement, if at all, after the shoulder injection.  
75% of patients found > 75% pain relief within 0 to 6 months and 72.5% of 
patients had > 75% ROM improvement in 0 to 6 months. 
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DISCUSSION 
Systematic Review Discussion 
One of the goals of the systematic review was to determine the effect of 
corticosteroid injections on outcomes of adhesive capsulitis. The review of the 
literature indicates corticosteroid injections offer initial improvements in pain and 
function scores of the shoulder for the first 1-6 weeks. However, beyond 6 to 12 
weeks, corticosteroid injections may not offer significantly added benefits in 
improving pain and ROM compared to physical therapy. Studies comparing 
corticosteroid injection to manipulation under anesthesia or dilation are mixed. 
Image-guided injections can offer improvements in function, pain, and ROM 
within the first 12 weeks. 
Of the studies that looked at steroid injections alone or along with a placebo 
injection, the results are mixed. Both studies showed range of motion and pain 
improvement was found for injection groups at the end of their study periods (12 
weeks) (Ahmad et al., 2009; Bal et al., 2008). However, one study showed a 
percent change from baseline in measurement outcomes that was similar to that 
of a placebo injection (Bal et al., 2008). 
Four studies showed that corticosteroid injections alone are at least as 
effective as a course of physical therapy alone. While improvements were 
statistically significant, there were no significant differences between 
corticosteroid injection and physical therapy at the end of their study (Arslan & 
Çeliker, 2001; Carette et al., 2003; Ryans et al., 2005). However, in the four 
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studies that examined a combination of both injection and physical therapy, three 
studies showed the combination group had greater improvements in certain 
outcomes measures at the end of the study period compared to treatments of 
either injection or physical therapy alone (Carette et al., 2003; Levine et al., 2007; 
Ryans et al., 2005). 
Of the four studies that examined the use of manipulation under anesthesia 
(MUA), all studies showed no significant differences between their treatment 
groups at the end of their studies. However, one study found the manipulation 
group to reach significant improvement six weeks earlier than the steroid 
injection group (De Carli et al., 2012). Two studies compared MUA against 
injection, one study compared mobilizations against injection, ice therapy, and no 
treatment and one study compared MUA alone versus MUA and injection 
(Bulgen et al., 1984; De Carli et al., 2012; Jacobs et al., 2009; Kivimäki & 
Pohjolainen, 2001). 
The results of dilation or distension of the glenohumeral joint compared to 
injection is also mixed. One study showed that there was a statistically significant 
improvement for the distension group compared to steroid alone in range of 
motion measures except in abduction, although this study did not quantify their 
findings (Gam et al., 1998). However, another study showed no statistical 
differences in ROM measures or in SPADI score 6 weeks after injection (Tveitå 
et al., 2008). 
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Based on results of studies that compared steroid dosages, location of 
injection, or types of steroid, it appears that injections of intra-articular, 40 mg 
triamcinolone acetate provide the greatest relief in terms of pain and ROM 
improvement as opposed to extra-articular injections, injections of 
methylprednisolone or 10 mg triamcinolone acetetate, or oral prednisolone. 
However, one study showed very little difference amongst intra-articular or intra-
bursal injections of either steroid or anesthetic (Rizk, R S Pinals, & Talaiver, 
1991). 
Other studies found success with a combination of one or more treatment 
modalities such as injection, distention, an abduction splint, suprascapular nerve 
block, MUA, and hydrodilation. One study found hydrodilation to have better 
effects than MUA in combination with an injection of triamcinolone acetonide in 
terms of VAS and Constant-Murley scores (Quraishi et al., 2007). Another study 
showed that injection and joint distension with normal saline had a greater effect 
on abduction and pain compared to MUA (Sharma et al., 1993). 
Although a clear conclusion on the long-term effectiveness of corticosteroid 
injections cannot be made, several studies show that injections can create rapid 
relief of pain and increase ROM in early stages of treatment. For example, in the 
Bal et al. study, after 2 weeks of follow-up, the steroid injection group had 
statistically significant greater changes in abduction, SPADI-total score, and 
SPADI-pain score over the placebo injection group (36.5 vs. 18.7, -30.9 vs. 20.2, 
and -30.1 and -19.0) (Bal et al., 2008). Another study showed that at 6 weeks, 
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steroid injections had a significant improvement over a physical therapy group in 
SDQ and SPADI-global score but not in passive external rotation (Ryans et al., 
2005). Another showed that a treatment combination of corticosteroid injection 
and physical therapy had the greatest improvements in active and passive ROM 
followed by corticosteroid injection alone, then physical therapy, and then 
placebo injection, but not after six months (Carette et al., 2003). Bulgen et al. 
found that compared to shoulder mobilizations, ice therapy, and benign neglect, 
methyl prednisolone injections showed the most rapid relief in range of motion 
measures but only up to six weeks (Bulgen et al., 1984). 
The second objective of this study was to evaluate the effectiveness of 
injections guided by fluoroscopy or ultrasonography. However, there is paucity of 
data on the utility of image guidance when performing glenohumeral 
corticosteroid injections. Only eight studies in this review reported an image-
guided injection technique that ensured intra-articular placement of all 
corticosteroid injections - five used fluoroscopy and three used ultrasound 
(Carette et al., 2003; De Carli et al., 2012; Gam et al., 1998; Lee et al., 2009; 
Lorbach, Anagnostakos, et al., 2010; Lorbach, Kieb, et al., 2010; Mitra et al., 
2009; Tveitå et al., 2008). Based on these studies, image-guided injections were 
effective for improving range of motion and pain. Seven of these studies reported 
statistically significant improvements in ROM at week 12 of follow-up or earlier for 
groups receiving an image guided corticosteroid injection(Carette et al., 2003; De 
Carli et al., 2012; Lee et al., 2009; Lorbach, Anagnostakos, et al., 2010; Lorbach, 
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Kieb, et al., 2010; Mitra et al., 2009; Tveitå et al., 2008). According to one study, 
ultrasound guided injections may be more effective than blind injections for the 
first few weeks. This study showed ultrasound guided injections were favorable 
to blind injections in flexion up to three weeks (p <.04), abduction up to two 
weeks (p < .02), internal rotation up to four weeks (p < .05), and VAS up to two 
weeks (p <.008)(Lee et al., 2009). Based on these studies, ultrasound guided 
injections seem to be effective for improving range of motion and pain and 
according to one study, more effective than blind injections for the first few 
weeks. However, there is a need for more studies investigating the role of image-
guided corticosteroid injections, and in particular, ultrasound-guided injections 
specifically for the treatment of adhesive capsulitis. 
The advantage of an ultrasound or fluoroscopically guided corticosteroid 
injection lies in giving the clinician the ability to more accurately guide an injection 
into the glenohumeral joint as opposed to the clinician relying on anatomical 
landmarks to guide his or her injections. Some studies show an alarmingly low 
accuracy of blind injection placement. Eustace et al. determined that the overall 
success rate for glenohumeral injections using a blind standardized anterior 
approach was only 42% (Eustace, Brophy, Gibney, Bresnihan, & Fitzgerald, 
1997). A study comparing two blind injection techniques showed a 0/20 success 
rate for the tender or trigger point technique and a 6/23 success rate for the 
functional or tension point technique for patients with adhesive capsulitis 
(Hollingworth, Ellis, & Hattersley, 1983). In a study seeking to determine the 
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accuracy of joint injections, Jones reported that only 2 of 20 shoulder injections 
actually reached the intra-articular space (Jones et al., 1993). In a cadaveric 
study by Sethi et al., only 27% of injections were actually intra-articular and the 
authors concluded that without some form of radiologic guidance, an accurately 
placed intra-articular glenohumeral injection in awake patients would be unlikely 
(Sethi, Kingston, & Elattrache, 2005). 
Ultrasound and fluoroscopy are both tools available to clinicians that can 
provide real-time imaging to assist guidance of injections and to improve injection 
placement. Ultrasound uses high-frequency sound waves to create images, while 
fluoroscopy uses x-rays to track a contrast agent in the body. Ultrasound offers 
certain advantages over fluoroscopy in the guidance of injections. Ultrasound 
allows for the visualization of soft tissues such as tendons, muscles, and 
neurovascular structures which can enhance accuracy of needle placement for 
injections (Finnoff, Hurdle, & Smith, 2008). Other advantages of ultrasound 
include not having to expose the patient and clinician from radiation inherent in 
fluoroscopy and eliminating the use of contrast agents that may cause 
complications for patients (Finnoff et al., 2008). One study compared ultrasound 
and fluoroscopically guided injections into the glenohumeral joint and found that 
an accurate injection into the glenohumeral joint on the first attempt occurred 
more often using ultrasound guidance injection (94%) compared to fluoroscopic 
guidance (72%). This study also found that US guidance used less overall 
procedure time than fluoroscopic guidance (>50%) (Rutten et al., 2009). 
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Some studies show that ultrasound guided injections improve clinical 
outcomes for shoulder pain and stiffness for conditions not specific to adhesive 
capsulitis. Chen et al. compared the clinical effectiveness of an injection 
treatment for subacromial burstitis based on whether a blind or an ultrasound 
guided method was used. They found only the ultrasound-guided injection group 
had a significant improvement in abduction ROM (Chen et al., 2006). Naredo et 
al. conducted a randomized controlled trial for “painful shoulder” that compared a 
group receiving triamcinolone injections under the guidance of ultrasound versus 
a group receiving blind injections. The study determined that at six weeks, the 
group receiving ultrasound-guided injections had a significant advantage over the 
blind injection group in measurement outcomes of shoulder function assessment 
(SFA) and visual analog scale (VAS) (Naredo et al., 2004). Ucunu et al. 
compared randomized groups of equal numbers receiving a triamcinolone 
injection guided either by ultrasound or by exterior anatomical landmarks for 
relief of shoulder pain. The authors found greater numbers of subjects in the 
ultrasound-guided group had ≥ 50% improvements in VAS and recovery to 
normal values of active and passive ROM. Both groups showed improvements in 
Constant score, a measurement outcome for shoulder function (Ucuncu et al., 
2009). Gilliland et al. evaluated clinical efficacy and accuracy of ultrasound with 
the standard anatomic injections for shoulder, knee, wrist, and other joints. In 
their review, the authors concluded that accuracy and short-term clinical 
outcomes are indeed improved by ultrasound-guided injections (Gilliland, 
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Salazar, & Borchers, 2011). Sibbit et al. also found that “sonographic needle 
guidance significantly improves the performance and outcomes of outpatient 
[intra-articular] injections in a clinically significant manner” (Sibbitt et al., 2009). 
There were several limitations to this systematic literature review. First, the 
review included studies with varied study design, quality, study population, 
interventions, comparators, and outcome measures. The heterogeneous nature 
of the studies and their results made it difficult to draw comparisons across 
studies. Second, there were varying degrees of risk of bias within studies. For 
many studies it was not feasible to blind patients or health care providers due to 
the nature of the intervention (e.g. an operative procedure such as manipulation 
under anesthesia). But only 9 of the 26 studies clearly reported blinding of 
outcome assessors and the failure to do so could have potentially led to skewed 
outcome measures.  
 
Injection Study Discussion 
 
Glenohumeral corticosteroid injections guided by ultrasound are an effective 
and rapid treatment for adhesive capsulitis. Patients showed declines in both 
average and worst pain scores at each follow-up period. There was also an 
improvement in range of motion parameters in forward flexion, isolated 
abduction, and external rotation after the first follow-up. Subjective shoulder 
value improvements indicate patients find significant recovery in pain and 
function. The majority of patients report greater than 75% overall improvement in 
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both shoulder pain and function after the injection at final follow-up. The greatest 
improvements in shoulder pain and function occurred at first follow-up. 
Ultrasound guided corticosteroid injection offer rapid pain and range of motion 
relief. Around half of patients found substantial pain and range of motion relief 
within 3 months. The majority of patients found pain and range of motion relief 
within 6 months. The greatest amount of pain and range of motion relief happen 
at the early stages of treatment. Improvements in shoulder pain and function are 
greatest after the first short-term follow-up. Afterwards, shoulder improvements 
are more gradual. In this study, improvements in average pain, worst pain, SSV, 
and external rotation were seen at each follow-up period, but they were only 
significant from baseline to the first follow-up period. However, 15% of all injected 
patients had not yet found pain relief and 10% had not yet found range of motion 
improvement after corticosteroid injection at the time of final follow up. 
The natural history of adhesive capsulitis does not involve rapid relief of pain 
and motion in the early stages of the condition. Thus, we believe our findings 
indicate that ultrasound guided corticosteroid injections are responsible for 
improving shoulder pain and range of motion within the first few months of 
treatment. To the best of our knowledge, this study is the first to examine both 
short and long-term outcomes of ultrasound guided glenohumeral corticosteroid 
injections for adhesive capsulitis. We recommend patients be treated with an 
early course of ultrasound guided injections of a corticosteroid steroid to help 
manage the most painful stage of this condition.  
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There were several limitations present to the injection study. First, the design 
of the study did not include a comparative control group. Having a control group, 
particularly one that received an injection without ultrasound guidance, could 
have facilitated stronger conclusions about the influence of ultrasound on 
adhesive capsulitis outcomes. Second, the final telephone follow-up primarily 
relied on patient response. The addition of a more objective measurement may 
have allowed for clearer conclusions, particularly that of shoulder ROM 
outcomes.  
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CONCLUSIONS AND FUTURE DIRECTIONS 
Literature Review Conclusion 
 
Corticosteroid injections seem to offer rapid relief of pain and improved ROM 
in the shoulder although conclusions cannot be made for the long term. However, 
there is a need for more conclusive studies to determine the clinical outcomes of 
corticosteroid injections for adhesive capsulitis – very few studies involving 
ultrasound-guided injections aim to assess their effect on clinical outcomes 
specifically for the condition of adhesive capsulitis. We believe there is demand 
for studies that seek to measure the effect of ultrasound-guided corticosteroid 
injections on outcomes of pain and range of motion for adhesive capsulitis 
patients in both the short and long term. 
 
Injection Study Conclusion 
Ultrasound is a useful tool that can be used in conjunction with corticosteroid 
injections in the treatment of adhesive capsulitis. In this study, many patients 
found rapid relief in pain and function in their shoulders after the injection. 
However, more studies are needed to further evaluate the effect of ultrasound 
guided injections on outcomes specifically for adhesive capsulitis. In particular, 
stronger study designs, such as a randomized trial with a control group not 
receiving an ultrasound guided injection, may better validate the use of 
ultrasound-guided injections in the treatment of adhesive capsulitis. Studies 
could also follow-up with patients at more frequent intervals to more accurately 
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determine the time frame of pain and function relief from time of injection. Also, a 
more complete understanding of the natural history of adhesive capsulitis and its 
specific pathophysiology could determine if treatments are altering or shortening 
the natural progression of this condition. Finding a method to follow the 
progression of a course of adhesive capsulitis would be invaluable. Another 
possible future direction of study for adhesive capsulitis ultrasound-guided 
injection trials would be to do determine factors or co-morbidities that predict 
either positive or negative responses after a corticosteroid intervention. 
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APPENDIX A 
INJECTION QUESTIONNAIRE 
 
1. If 100% represents a completely normal shoulder that has no pain and is fully functional, and 0 
represents one that has the worst possible pain and function, what value would you give your 
shoulder in the last two weeks on a scale of 0 to 100? 
 
Right:  ______%  Left:  ______% 
 
2. Please rate your AVERAGE pain during the last two weeks. The number 0 represents “no 
pain” and 10 represents the “worse possible pain.” Please circle the number that best describes 
your pain in the last two weeks.  
  
 
 
3. Please rate your WORST pain during the last two weeks. The number 0 represents “no pain” 
and 10 represents the “worse possible pain.” Please circle the number that best describes your 
pain in the last two weeks.  
 
 
 
4. How much overall improvement in your shoulder pain do you have now as compared to before 
the injection?  
 
 □ No improvement  □ 25%   □ 50%   
 □ 75%    □ 90%   □ 100% 
 
5. How much overall improvement in your shoulder function do you have now as compared to 
before the injection?  
 
 □ No improvement  □ 25%   □ 50%   
 □ 75%    □ 90%   □ 100% 
 
6. How long did it take you after the shoulder injection performed by Dr. Jain to get >75% pain 
relief? 
 
 □ 0-3 months  □ 3-6 months □ 6-9 months  □ 9-12 months 
 □ 12-18 months  □ >18 months □ Have not achieved >75% pain relief as yet 
 
7. How long did it take you after the shoulder injection performed by Dr. Jain to get >75% range 
of motion improvement? 
 
□ 0-3 months  □ 3-6 months  □ 6-9 months □ 9-12 months 
 □ 12-18 months  □ >18 months □ Have not achieved >75% improvement in 
range of motion as yet 
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